Date published: 2026-3-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

TPO Inhibitors

TPO inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Thyroid Peroxidase (TPO), an essential enzyme involved in the synthesis of thyroid hormones. TPO is a heme-containing enzyme located in the thyroid gland's follicular cells and plays a critical role in catalyzing the iodination of tyrosine residues in thyroglobulin, a precursor protein, and the subsequent coupling of iodotyrosines to form the active thyroid hormones, thyroxine (T4) and triiodothyronine (T3). These hormones are crucial for regulating metabolism, growth, and development in various tissues throughout the body. By inhibiting TPO, researchers can disrupt the synthesis of thyroid hormones, offering a valuable tool for studying the biochemical pathways underlying thyroid hormone production and its regulation.

In research settings, TPO inhibitors are instrumental in exploring the molecular mechanisms that control thyroid hormone biosynthesis and the broader implications of thyroid hormone regulation on metabolic processes. By blocking TPO activity, scientists can investigate how the inhibition affects the various steps in the thyroid hormone synthesis pathway, including iodide oxidation, iodination of tyrosine residues, and the coupling reactions that lead to hormone formation. This inhibition allows researchers to study the downstream effects of reduced thyroid hormone levels on cellular metabolism, gene expression, and physiological processes in target tissues. Additionally, TPO inhibitors provide insights into the regulatory networks that control TPO activity and thyroid hormone synthesis, such as the role of iodine availability, feedback mechanisms, and interactions with other enzymes involved in thyroid function. Through these studies, the use of TPO inhibitors enhances our understanding of the biochemical and physiological processes underlying thyroid hormone production, the regulation of metabolic activity, and the broader impact of thyroid function on overall health and development.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Eltrombopag

496775-61-2sc-207614
sc-207614A
sc-207614B
5 mg
50 mg
100 mg
$263.00
$381.00
$490.00
1
(0)

Small molecule TPO receptor agonist, indirectly influences TPO activity.

Anagrelide hydrochloride

58579-51-4sc-203513
sc-203513A
10 mg
50 mg
$103.00
$587.00
1
(0)

Reduces platelet production, potentially affecting TPO-related pathways.

Danazol

17230-88-5sc-203021
sc-203021A
100 mg
250 mg
$92.00
$238.00
3
(0)

Alters levels of growth factors affecting blood cells, potentially impacting TPO activity.

Mycophenolate mofetil

128794-94-5sc-200971
sc-200971A
20 mg
100 mg
$37.00
$109.00
1
(1)

Immunosuppressant, can affect bone marrow and thus indirectly influence TPO activity.

Cyclophosphamide

50-18-0sc-361165
sc-361165A
sc-361165B
sc-361165C
50 mg
100 mg
500 mg
1 g
$90.00
$146.00
$469.00
$791.00
18
(1)

Alkylating agent, impacts bone marrow, potentially affecting TPO pathways.

Azathioprine

446-86-6sc-210853D
sc-210853
sc-210853A
sc-210853B
sc-210853C
500 mg
1 g
2 g
5 g
10 g
$203.00
$176.00
$349.00
$505.00
$704.00
1
(1)

Immunosuppressive drug, may influence hematopoiesis and indirectly TPO activity.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Antineoplastic drug, affects bone marrow function, potentially impacting TPO.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Modulates immune response and angiogenesis, potentially affecting TPO pathways.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Immunomodulatory drug, affects bone marrow microenvironment, potentially influencing TPO.

Busulfan

55-98-1sc-204658
10 g
$49.00
3
(1)

Alkylating agent, affects hematopoiesis, potentially impacting TPO activity.